Over 1750 Total Lots Up For Auction at Five Locations - MA 04/30, NJ Cleansweep 05/02, TX 05/03, TX 05/06, NJ 05/08

AMA applauds Trump administration's creation of opioids commission

Press releases may be edited for formatting or style | March 30, 2017 Business Affairs Risk Management
March 30, 2017, CHICAGO -- The American Medical Association (AMA) said today it looks forward to working with the Trump administration's new commission to create policies intended to end the opioid epidemic sweeping the country.

"The AMA has been a leader in developing a comprehensive response to the opioid epidemic, and we are excited to share the expertise of the nation's physicians on this topic. Our Task Force to Reduce Opioid Abuse has issued recommendations and worked to raise awareness within the physician community," said AMA Board Chair Patrice A. Harris, MD.

"We are poised to offer guidance in areas of effective public health approaches, best practices, clinical tools, medication-assisted treatment, and barriers to effective treatment. We want to emphasize the need to treat substance use disorder as a medical illness and eliminate the stigma associated with seeking treatment for pain and substance abuse."

The AMA has a new education module that offers clinicians a review of the basic approaches and actions to reduce opioid-related harm in patients with acute or chronic pain. To learn more about the AMA's efforts to end the epidemic of opioid overdose deaths, visit AMA Wire.


About the American Medical Association
The American Medical Association is the premier national organization providing timely, essential resources to empower physicians, residents and medical students to succeed at every phase of their medical lives. Physicians have entrusted the AMA to advance the art and science of medicine and the betterment of public health on behalf of patients for more than 170 years. For more information, visit ama-assn.org.

You Must Be Logged In To Post A Comment